TIAA CREF Investment Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $1.01M | Buy |
64,068
+6,423
| +11% | +$101K | ﹤0.01% | 2317 |
|
|
2018
Q4 | $1.16M | Sell |
57,645
-18,040
| -24% | -$363K | ﹤0.01% | 2228 |
|
|
2018
Q3 | $1.88M | Sell |
75,685
-35,935
| -32% | -$893K | ﹤0.01% | 2147 |
|
|
2018
Q2 | $3.06M | Buy |
111,620
+44,385
| +66% | +$1.22M | ﹤0.01% | 1938 |
|
|
2018
Q1 | $2.07M | Buy |
67,235
+4,372
| +7% | +$135K | ﹤0.01% | 2078 |
|
|
2017
Q4 | $2.25M | Buy |
62,863
+2,759
| +5% | +$98.6K | ﹤0.01% | 2071 |
|
|
2017
Q3 | $1.66M | Buy |
60,104
+595
| +1% | +$16.4K | ﹤0.01% | 2265 |
|
|
2017
Q2 | $1.57M | Sell |
59,509
-15,765
| -21% | -$416K | ﹤0.01% | 2324 |
|
|
2017
Q1 | $1.57M | Sell |
75,274
-2,413
| -3% | -$50.2K | ﹤0.01% | 2280 |
|
|
2016
Q4 | $1.61M | Buy |
77,687
+6,534
| +9% | +$135K | ﹤0.01% | 2300 |
|
|
2016
Q3 | $1.15K | Buy |
71,153
+9,564
| +16% | +$155 | ﹤0.01% | 2471 |
|
|
2016
Q2 | $838K | Buy |
61,589
+5,874
| +11% | +$79.9K | ﹤0.01% | 2605 |
|
|
2016
Q1 | $973K | Hold |
55,715
| – | – | ﹤0.01% | 2484 |
|
|
2015
Q4 | $1.9M | Buy |
55,715
+3,187
| +6% | +$109K | ﹤0.01% | 2186 |
|
|
2015
Q3 | $1.56M | Sell |
52,528
-1,155
| -2% | -$34.4K | ﹤0.01% | 2294 |
|
|
2015
Q2 | $1.72M | Buy |
53,683
+22,050
| +70% | +$705K | ﹤0.01% | 2398 |
|
|
2015
Q1 | $656K | Buy |
31,633
+2,240
| +8% | +$46.5K | ﹤0.01% | 2833 |
|
|
2014
Q4 | $498K | Buy |
29,393
+521
| +2% | +$8.83K | ﹤0.01% | 2966 |
|
|
2014
Q3 | $558K | Hold |
28,872
| – | – | ﹤0.01% | 2929 |
|
|
2014
Q2 | $982K | Buy |
28,872
+6,794
| +31% | +$231K | ﹤0.01% | 2735 |
|
|
2014
Q1 | $695K | Buy |
+22,078
| New | +$695K | ﹤0.01% | 2825 |
|